METABOLIC SYNDROM, RISK FACTOR FOR CARDIOVASCULAR DISEASE

T. Novaković ,
T. Novaković

Internal clinic, Faculty of Medicine , Priština, Kosovska Mitrovica , Kosovo*

A. Jovanović ,
A. Jovanović

Internal clinic, Faculty of Medicine , Priština, Kosovska Mitrovica , Kosovo*

S. Sovtić ,
S. Sovtić

Internal clinic, Faculty of Medicine , Priština, Kosovska Mitrovica , Kosovo*

S. Pajović
S. Pajović

Internal clinic, Faculty of Medicine , Priština, Kosovska Mitrovica , Kosovo*

Published: 01.12.2004.

Volume 32, Issue 2 (2004)

pp. 43-46;

https://doi.org/10.70949/pramed200402087N

Abstract

Sindrom X or Metabolic Syndrome are both terms used to describe a collection of herth risks contitions that increase your chance os developing heart disease, stroke and diabetes. The condition is aslo known by other names including insulin Resistence syndrome, and Dysmetabolic syndrome. The number of people with Metabolic Syndrome increases with
age, affecting more than 40 percent of people in their 60 s and 70 s. Components of Metabolic Syndrome are: Abdominal obesity, atherogenic dyslipidemia, raised blood pressure, insulin resistance, proinflamate state and prothrombotic state. The
National Cholesterol Education Program 's Adult Treatment Panel III report (ATPIII) identified 6 components of the metabolic syndrome that relevate to CVD. Insulin resistance is present in the majority of people with the matabolic syndrome.
It strongly associates is present with other metabolic risk factors and correlates unuvariately with CVD risk. Patiens with
longstanding insulin resistance frequently manifest glucose intolerance. When glucose intolerance evolves into diabetslevel hyperglicemia, independent risk factor for CVD. When 3 of 5 of the listed caracteristics are present, a diagnosis of metabolic syndrome can be made. The exact cause of Metabolic syndrome is not known. Most reserchers believe it is caused by
a combination of your genetic makeup and lifestyle choices-including the types of food you eat and level of physical activity.

Keywords

References

1.
G. R, F. A, T M. Obesity, insulin resistance, and cardiovascular disease. Journal Article Review, United States.
2.
Reaven GM. Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes. 37:1595–607.
3.
F. A, BW. B, C. L. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol. 40:937–43.
4.
S. F, T. F, M. S, M. I, Y. Y, Y. N, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. Clin Invest. 114:1752–61.
5.
CJ. B, Med TRCMNEJ. 334:574 9.
6.
E. F, SM. H, BD. M. Hyperinsulinemia, the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 34:416–22.
7.
DS. L, MA. P, CH. K, JE. H, Horn L., ML. S, et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA. 282:1539–44.
8.
Anderson W. Whole grains and coronary heart disease: The whole kernel of truth. Am J Clin Nutr December. 1:1459–60.
9.
Galle AME. Starting treatment for diabetes: The Practitioner. 231:1443–9.
10.
HM. L, DE. L, TA. L. Prediction of coronary heart disease using risk factor categories. Circulation. 97:1837–47.
11.
The Oxford Centre for Diabetes, Endocrinology, and Metabolism Diabetes Trials Unit. UKPDS Risk Engine December. 12.
12.
H. R, D P. Theory and Practice. In: Ellenberg and Rifkin’s Diabetes Mellitus.
13.
Watts GF. Cholesterol and Coronary Heart Disease: Discovering the Link.
14.
Jovanović M. Aktivna život s dijabetesom.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by